Figure 6.

Dissolution profiles of AS and AQ bilayer ASAQ tablets compared to commercially available reference tablets. Key: Panel A: dissolution profiles of AS in high (30154C03) and low (30154C04) dosage bilayer ASAQ tablets compared to commercialized AS tablets Arsumax^®

Panel B: dissolution profiles of AQ of high (30154C03) and low (30154C04) dosage bilayer ASAQ tablets compared to commercialized AQ tablets Flavoquine^®.